Is OPESF or JNJ a better dividend investment in 2026?

OPESF currently yields 121.20% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: OPESF offers higher current income.

What is the dividend yield difference between OPESF and JNJ?

OPESF has a forward dividend yield of 121.20% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 117.84 percentage points.

Home › Compare › OPESF vs JNJ

OPESF vs JNJ: Dividend Comparison 2026

OPESF yields 121.20% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 OPESF wins by $8.92M in total portfolio value

INVESTMENT

TIME HORIZON10 years

OPESF

● Live price

121.20%

Share price

$1.65

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.94M

Annual income

$3,409,533.06

Full OPESF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — OPESF vs JNJ

📍 OPESF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	OPESF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, OPESF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

OPESF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OPESF

Annual income on $10K today (after 15% tax)

$10,302.41/yr

After 10yr DRIP, annual income (after tax)

$2,898,103.10/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, OPESF beats the other by $2,897,399.49/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OPESF + JNJ for your $10,000?

OPESF: 50%JNJ: 50%

100% JNJ50/50100% OPESF

Portfolio after 10yr

$4.48M

Annual income

$1,705,180.42/yr

Blended yield

38.05%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OPESF

No analyst data

Altman Z

13.4

Piotroski

4/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OPESF buys

JNJ buys

No recent congressional trades found for OPESF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricOPESFJNJ

Forward yield	121.20% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$8.94M	$20.0K ✓
Annual income after 10y	$3,409,533.06 ✓	$827.78
Total dividends collected	$8.14M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: OPESF vs JNJ ($10,000, DRIP)

Year	OPESF Portfolio	OPESF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$22,820	$12,120.48	$10,676	$355.77	+$12.1K → OPESF
2	$50,268	$25,850.01	$11,407	$389.39	+$38.9K → OPESF
3	$107,003	$53,216.10	$12,198	$426.53	+$94.8K → OPESF
4	$220,361	$105,867.69	$13,056	$467.62	+$207.3K → OPESF
5	$439,546	$203,759.89	$13,987	$513.12	+$425.6K → OPESF
6	$850,158	$379,843.75	$14,998	$563.56	+$835.2K → OPESF
7	$1,596,289	$686,620.22	$16,098	$619.52	+$1.58M → OPESF
8	$2,912,912	$1,204,882.82	$17,295	$681.69	+$2.90M → OPESF
9	$5,171,651	$2,054,834.67	$18,599	$750.82	+$5.15M → OPESF
10	$8,943,199	$3,409,533.06	$20,022	$827.78	+$8.92M → OPESF

OPESF vs JNJ: Complete Analysis 2026

OPESF — Stock

Otello Corporation ASA provides cloud-based network solutions for mobile operators. It offers RocketColony, which enables mobile operators to optimize their network performance and quality. The company was formerly known as Opera Software ASA and changed its name to Otello Corporation ASA in January 2018. Otello Corporation ASA was founded in 1995 and is based in Oslo, Norway.

Full OPESF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this OPESF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OPESF vs SCHD OPESF vs JEPI OPESF vs O OPESF vs KO OPESF vs MAIN OPESF vs ABBV OPESF vs MRK OPESF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.